by In2Pharma | Oct 20, 2025 | News
The Netherlands Recent updates to the Dutch Medicines Act (Geneesmiddelenwet) of 8 February 2007 have been published. This Act defines the composition and responsibilities of the Medicines Evaluation Board (MEB) and regulates the licensing of manufacturers,...
